Literature DB >> 22580815

Rapid palliative radiotherapy unit: multidisciplinary management of bone metastases.

V Donato1, M Cianciulli, M Crescenzi, A Monaco, C Caruso, A Morrone.   

Abstract

PURPOSE: The aim of this study was to highlight the advantages of rapid access to a palliative radiotherapy unit adopting a multidisciplinary approach to symptom management to relieve pain and improve quality of life in patients with bone metastases.
MATERIALS AND METHODS: From January 2007 to December 2008, 142 oncological patients were treated with linear accelerator radiotherapy (RT) administered in a single 8-Gy fraction. The European Organization for Research and Treatment Quality of Life Questionnaire (EORTC QLQ-C30) was administered to each patient at admission and at subsequent intervals. A traditional simulator was used to define the correct patient setup, and all treatment plans were performed with a two-dimensional technique..
RESULTS: Ninety-six patients agreed to fill in the EORTC QLQ-C30 questionnaire; 80 actually completed it. Twelve weeks after RT, a reduction in pain level compared with baseline (T0) was recorded, which was classified as 1 in 36 patients (45%) and 2 in 44 patients (55%). Pain interference with daily activities was also recorded, with significantly reduced scores with respect to T0: 1 in eight patients (10%), 2 in 28 patients (35%) and 3 in 44 patients (55%); quality of life scores also improved with respect to T0: 2 in 28 patients (35%), 3 in 23 patients (29%), 4 in 22 patients (27%) and 5 in seven patients (9%).
CONCLUSIONS: The proposal for treating patients with painful bone metastases with a single 8-Gy fraction of RT, with all the procedures being performed on the same day, offers many advantages in terms of pain relief, quality of life and clinical management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580815     DOI: 10.1007/s11547-012-0834-6

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  23 in total

1.  Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.

Authors:  Stein Kaasa; Elisabeth Brenne; Jo-Asmund Lund; Peter Fayers; Ursula Falkmer; Matts Holmberg; Magnus Lagerlund; Oivind Bruland
Journal:  Radiother Oncol       Date:  2006-06-21       Impact factor: 6.280

2.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

3.  Factors affecting the use of palliative radiotherapy in Ontario.

Authors:  J Huang; S Zhou; P Groome; S Tyldesley; J Zhang-Solomans; W J Mackillop
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

4.  Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.

Authors:  E Chow; C Danjoux; R Wong; E Szumacher; E Franssen; K Fung; J Finkelstein; L Andersson; R Connolly
Journal:  Radiother Oncol       Date:  2000-09       Impact factor: 6.280

5.  An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.

Authors:  C Danjoux; E Chow; A Drossos; L Holden; C Hayter; M Tsao; T Barnes; E Sinclair; M Farhadian
Journal:  Support Care Cancer       Date:  2005-04-23       Impact factor: 3.603

6.  The rapid access palliative radiotherapy program: blueprint for initiation of a one-stop multidisciplinary bone metastases clinic.

Authors:  A Fairchild; E Pituskin; B Rose; S Ghosh; J Dutka; A Driga; P Tachynski; J Borschneck; L Gagnon; S Macdonnell; J Middleton; K Thavone; S Carstairs; D Brent; D Severin
Journal:  Support Care Cancer       Date:  2008-06-20       Impact factor: 3.603

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 8.  Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy.

Authors:  Nicole M E Bradley; Janice Husted; Michael Sai Lai Sey; Amna F Husain; Emily Sinclair; Kristin Harris; Edward Chow
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.359

9.  Awareness and use of the Rapid Palliative Radiotherapy Program by family physicians in Eastern Ontario: a survey.

Authors:  E J Fitzgibbon; R Samant; J Meng; I D Graham
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

10.  Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients.

Authors:  F Amouzegar-Hashemi; H Behrouzi; A Kazemian; B Zarpak; P Haddad
Journal:  Curr Oncol       Date:  2008-06       Impact factor: 3.677

View more
  2 in total

1.  The Vancouver rapid access clinic for palliative lung radiation, providing more than just rapid access.

Authors:  Shilo Lefresne; Eric Berthelet; Rosemary Cashman; Karen Levy; Mitchel Liu; Hannah Carolan; Michael McKenzie; Paula Kostuik; Robert Olson
Journal:  Support Care Cancer       Date:  2014-07-08       Impact factor: 3.603

2.  Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model.

Authors:  Francesco Cellini; Rossella Di Franco; Stefania Manfrida; Valentina Borzillo; Ernesto Maranzano; Stefano Pergolizzi; Alessio Giuseppe Morganti; Vincenzo Fusco; Francesco Deodato; Mario Santarelli; Fabio Arcidiacono; Romina Rossi; Sara Reina; Anna Merlotti; Barbara Alicja Jereczek-Fossa; Angelo Tozzi; Giambattista Siepe; Alberto Cacciola; Elvio Russi; Maria Antonietta Gambacorta; Marta Scorsetti; Umberto Ricardi; Renzo Corvò; Vittorio Donato; Paolo Muto; Vincenzo Valentini
Journal:  Radiol Med       Date:  2021-09-27       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.